Cyrus Karkaria
Corporate Officer/Principal presso LUPIN LIMITED
Posizioni attive di Cyrus Karkaria
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LUPIN LIMITED | Corporate Officer/Principal | 07/10/2011 | - |
Storia della carriera di Cyrus Karkaria
Precedenti posizioni note di Cyrus Karkaria
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - | - |
Formazione di Cyrus Karkaria
| University of Maryland | Doctorate Degree |
| University of Mumbai | Graduate Degree |
| Harvard Medical School | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| India | 3 |
Posizioni
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LUPIN LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
- Borsa valori
- Insiders
- Cyrus Karkaria
- Esperienza
